Real Life Dosing Regimen of Remicade [infliximab] in Austria, Monitored Over 9 Consecutive Infusions in Rheumatoid Arthritis Therapy.
Phase of Trial: Phase IV
Latest Information Update: 05 Nov 2013
At a glance
- Drugs Infliximab (Primary)
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
- Sponsors Merck & Co; Schering-Plough
- 08 Oct 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 08 Oct 2010 Actual end date (Jul 2010) added as reported by ClinicalTrials.gov.
- 19 Aug 2009 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov